(Q48556350)

12 February 2018

reason for preferred rank

title

Reversal of reserpine-induced bradykinesia bya-methyldopa - new light on its modus operandi (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

8 March 2023

Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4821419

8 March 2023

2

C D Marsden

1 reference

12 February 2018

R. C. Duvoisin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4821419

8 March 2023

C. D. Marsden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4821419

8 March 2023

language of work or name

English

0 references

publication date

1 May 1974

1 reference

12 February 2018

10 May 1974

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4821419

full work available at URL

8 March 2023

https://api.elsevier.com/content/article/PII:0006899374902042?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

https://api.elsevier.com/content/article/PII:0006899374902042?httpAccept=text/plain

8 March 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

8 March 2023

1 reference

12 February 2018

volume

71

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

178-182

1 reference

12 February 2018

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine

8 March 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

AWAKENING FROM RESERPINE SEDATION BY ALPHA-METHYLDOPA

8 March 2023

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

The recovery of noradrenaline in adrenergic nerve terminals of the rat after reserpine treatment.

8 March 2023

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

Effects of ?-methyl-Dopa on conditioned behaviour in the cat

8 March 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

EFFECT OF ALPHA-METHYL DOPA AND RESERPINE IN HUNTINGTON'S CHOREA, PARKINSON'S DISEASE AND OTHER MOVEMENT DISORDERS.

8 March 2023

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

A CONTROLLED CLINICAL TRIAL OF ALPHA METHYL DOPA IN PARKINSONIAN TREMOR.

8 March 2023

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

An investigation of a new instrument to measure motor activity of small animals

8 March 2023

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

Methyldopa as an adjunct to levodopa treatment of Parkinson's disease

8 March 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

REVERSAL OF THE EFFECT OF ALPHA-METHYLDOPA BY MONOAMINE OXIDASE INHIBITORS.

8 March 2023

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(74)90204-2

8 March 2023

Identifiers

1 reference

12 February 2018

1 reference

12 February 2018